About Us

Asia Kidney Research Ltd. (AKR) is committed to advancing the innovation landscape of kidney disease researchand renal drug development. In collaboration with world-class scientists in the field of stem cell and regenerativemedicine, the company focuses on building platforms for iPSC-derived kidney cells, kidney organoids, kidney organoidon-a-chip, and high-biomimetic simulation systems, providing cutting -edge technical services and integrated solutionsfor kidney disease research and drug discovery.

The company has established the Kidnioid Technology Platform, which encompasses an iPSC cell bank, a kidneyorganoid differentiation platform, a kidney organoid disease model bank, a kidney organoid on-a-chip platform, animalkidney disease models, molecular/protein analysis platforms, histopathology platforms, as well as kidney organoidculture and differentiation kit products - forming a comprehensive system dedicated to kidney disease research andrenal drug development. To date, the company has provided products and technical services to numerous clinicalnephrology departments, universities, research institutes, and pharmaceutical companies across China, earning thetrust of our clients and establishing itself as a leader in the domestic kidney organoid technology landscape.

The company serves as the specific research unit of the Aisa Regenerative Medicine - Sun Yat-sen University JointLaboratory. This Joint Laboratory brings together hundreds of kidney research and clinical experts from two medicalschools and 20 affiliated hospitals of Sun Yat-sen University.